Correction: Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways

समान संसाधन

• Molecular profiling of cetuximab and bevacizumab treatment of colorectal tumours reveals perturbations in metabolic and hypoxic response pathways
  द्वारा: Greening, David W., और अन्य
  प्रकाशित: (2015)
• Clinical impact of primary tumour location, early tumour shrinkage, and depth of response in the treatment of metastatic colorectal cancer with first-line chemotherapy plus cetuximab or bevacizumab
  द्वारा: Sagawa, Tamotsu, और अन्य
  प्रकाशित: (2020)
• Is more better than less? Caveats from bevacizumab and cetuximab combination in colorectal cancer
  द्वारा: Camillo Porta
  प्रकाशित: (2011-12-01)
• Molecular targeted treatment of metastatic colorectal cancer: the cardiovascular adverse effects of Bevacizumab and Cetuximab
  द्वारा: GHERMAN, ALEXANDRA, और अन्य
  प्रकाशित: (2017)
• Comparative effectiveness of bevacizumab, cetuximab, and panitumumab for improving outcomes in metastatic colorectal cancer: a propensity overlap weighting analysis
  द्वारा: Yi-Chia Su, और अन्य
  प्रकाशित: (2025-10-01)